Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 9/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.38 |
| ▸ | ULK1 | O75385 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | ITK | Q08881 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3256189 | 0.88 | MEN1 (0.47) | ABL1CCNA2CDK2GSK3AGSK3B | |
| SCHEMBL3556396 | 0.87 | ALOX15 (0.46) | ABL1CCNA2CDK2ALDH1A1HPGD | |
| SCHEMBL3257632 | 0.87 | ALOX15 (0.46) | ABL1CCNA2CDK2ALDH1A1HPGD | |
| SCHEMBL6390885 | 0.85 | HDAC1 (0.40) | HDAC1HDAC2HDAC3MAPK8MAPK10 | |
| SCHEMBL6390874 | 0.84 | HDAC1 (0.40) | HDAC1HDAC2HDAC3MAPK8MAPK10 | |
| SCHEMBL6390880 | 0.84 | HDAC1 (0.40) | HDAC1HDAC2HDAC3MAPK8MAPK10 | |
| SCHEMBL5867668 | 0.81 | ABL1 (0.43) | ULK1ABL1CDK2GSK3AGSK3B | |
| SCHEMBL3569427 | 0.80 | CDK2 (0.36) | HDAC1HDAC2HDAC3MAPK8MAPK10 | |
| SCHEMBL3127326 | 0.74 | PKM (0.40) | MAPK1CDK2GSK3BALDH1A1HPGD | |
| SCHEMBL3127315 | 0.74 | PKM (0.40) | MAPK1CDK2GSK3BALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7671072-B2 | Aminopyrazole derivatives as GSK-3 inhibitors | PFIZER INC. (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | BENBOW JOHN W | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276010-A1 | Aminopyrazole Derivatives as Gsk-3 Inhibitors | GSK3B, GSK3A, GSKIP | HDAC1 200/4885HDAC2 527/4885HDAC3 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.